Relationship Between Structure and Pathogenicity

Authors

  • Xinyu Yu

DOI:

https://doi.org/10.54097/wmckz126

Keywords:

COVID-19, variants, pathogenicity.

Abstract

The global COVID-19 crisis caused by the SARS-CoV-2 virus has led to the emergence of multiple variants, capturing substantial international attention. This extensive study offers a comprehensive examination of the structural attributes and disease-causing potential of the original SARS-CoV-2 strain and its primary variants, namely Alpha, Beta, Delta, Gamma, and Omicron.

Downloads

Download data is not yet available.

References

Huang, Y., Yang, C., Xu, Xf. et al. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin 41, 1141–1149 (2020).

Hu, B., Guo, H., Zhou, P. et al. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 19, 141–154 (2021).

Trobec, Tomaž. The role of the SARS-CoV-2 envelope protein as a pH-dependent cation channel. The Journal of physiology vol. 599, 14 (2021).

Kumar, Sudhir et al. An Evolutionary Portrait of the Progenitor SARS-CoV-2 and Its Dominant Offshoots in COVID-19 Pandemic. Molecular biology and evolution vol. 38, 8 (2021): 3046-3059.

Zhang, Lizhou et al. The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. bioRxiv: the preprint server for biology 2020.06.12.148726.

Meng, Bo et al. Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7. Cell reportsvol. 35, 13 (2021): 109292.

Davies, Nicholas G et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science (New York, N.Y.) vol. 372, 6538 (2021): eabg3055.

Mahase, Elisabeth. Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant. BMJ (Clinical research ed.) vol. 372 n296. 1 Feb. 2021.

Tegally, Houriiyah et al. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature vol. 592, 7854 (2021): 438-443.

Harvey, William T et al. SARS-CoV-2 variants, spike mutations and immune escape. Nature reviews. Microbiology vol. 19, 7 (2021): 409-424.

Baum, Alina et al. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science (New York, N.Y.) vol. 369, 6506 (2020): 1014-1018.

Garcia-Beltran, Wilfredo F et al. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell vol. 184, 9 (2021): 2372-2383.e9.

Li, Baisheng et al. Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant. Nature communications vol. 13, 1 460. 24 Jan. 2022

Earnest, Rebecca et al. “Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA.” medRxiv: the preprint server for health sciences 2021.10.06.21264641. 7 Oct. 2021.

Zhang, Jun et al. Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant. bioRxiv: the preprint server for biology 2021.08.17.456689. 17 Aug. 2021.

Hart, William S et al. Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis. The Lancet. Infectious diseases vol. 22, 5 (2022): 603-610.

Lupala, Cecylia S et al. “Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor.” Biochemical and biophysical research communications vol. 590 (2022): 34-41.

Vu, Michelle N et al. Loss-of-function mutation in Omicron variants reduces spike protein expression and attenuates SARS-CoV-2 infection. bioRxiv: the preprint server for biology 2023.04.17.536926. 10 Jul. 2023.

Downloads

Published

29-12-2023

How to Cite

Yu, X. (2023). Relationship Between Structure and Pathogenicity. Highlights in Science, Engineering and Technology, 74, 1347-1353. https://doi.org/10.54097/wmckz126